WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 2'9401 Infant (under 12 months) mortality rate: 282
GDP / capita (US$): 5'1931 Child (under 5 years) mortality rate: 332

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 32'521  32'059  31'642  31'277  30'955  28'710  24'675  19'799 
Births 739  720  696  670  645  631  740  770 
Surviving infants 719  700  676  650  625  605  697  698 
Pop. less than 5 years 3'234  3'077  2'984  2'913  2'892  3'118  3'457  3'229 
Pop. less than 15 years 9'035  8'927  8'899  8'902  8'963  9'776  9'987  8'716 
Female 15-49 years 9'176  9'125  9'048  8'962  8'858  7'804  5'941  4'534 

Number of reported case

(Click for retrospective incidence data for Morocco)
Diphtheria 43 
Japanese encephalitis
Measles 982  633  834  1'455  7'368  1'577  86'919 
Mumps
Pertussis 35  15  73  74  22  83  14'873 
Polio* 52 
Rubella
Rubella (CRS)
Tetanus (neonatal) 28 
Tetanus (total) 16  20  41  27  73  81 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Morocco)
Vaccine year result method % card seen                                                
BCG 2010  99  DHS   86.2  100  99  100  99  99  97  96 
DTP1 2010  98  DHS   86.2  100  99  100  99*  100  98 
DTP3 2010  95  DHS   86.2  99  99  100  99  99  95  81 
HepB_BD          20  99  99  99  97  10 
HepB3          99  98  98  98  97  43 
Hib3          99  98  100  99  99 
JapEnc         
MCV 2010  89  DHS   86.2  99  95  98  98  96  93  79 
MCV2          10 
PCV1          86  91  16 
PCV3          72  23 
Pol3 2010  95  DHS   86.2  99  98  100  99  99  95  81 
Rota1          91  87  17 
Rota_last          88  80 
Rubella1         
TT2plus 1994  54  DHS   51.0  90  64 
PAB         
VAD1          80  80  76  76  75  40 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Morocco)
BCG 99  99  99  99  99  97  96 
DTP1 99  99  99  99  99  98  93 
DTP3 99  99  99  99  99  95  81 
HepB3 99  98  98  98  97  43 
Hib3 99  99  99  99  99 
MCV 99  95  98  98  96  93  79 
PAB 89  89  89  87  90  86  66 
PCV3 72  23 
Pol3 99  98  99  99  99  95  81 
Rota_last 88  80 

Number of districts in the country 81  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 84
From 80 to 89% 15
From 50 to 79% 1
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 1 month; Yes
DTwP 18 months; 5 years; Yes
DTwPHibHepB 2, 3, 4 months; Yes
HepB birth; Yes
Measles 9 months; Yes
OPV 1, 2, 3, 4 months; Yes
Pneumo_conj 2, 4, 12 months;
Rotavirus 2, 3 months; Yes
TT 1st contact; +1, +6 months; +1, +1 year; Yes
VitaminA 6, 12, 18 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2008-2012  2008-2012  2008-2012  2010-2012  2009-20011  2006-2015  2006-2015 
Nº of districts with microplans that include activities to raise immunization coverage number 81  81  68  68  68  68  68 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 81  81  68  68  68  68  68 
Nº districts with DTP3 coverage >=80% number 80  79  68  68  67  64  67 
% of districts with DTP3 coverage >=80% From 0 to 100% 99  98  100  100  99  94  99 
Nº districts with measles (MCV1) coverage >=95% number 65  47  45  39  32     
% of districts with MCV1 coverage >=95% From 0 to 100% 80  58  66  57  47     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100%   100  92  100  100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.